Bmc Medical301367.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 19, 2026, Bmc Medical (301367.SZ) trades at a P/E of 26.00x, P/B of 1.88x, P/S of 3.77x, and a dividend yield of 1.02%.
Longitudinal percentile comparison: P/E sits at the 23rd percentile over the trailing 10Y window (vs. 18th percentile over 3Y); P/B sits at the 9th percentile over the trailing 10Y window (vs. 11th percentile over 3Y); P/S sits at the 3rd percentile over the trailing 10Y window (vs. 4th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 34th percentile within its industry and the 36th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.06%, ranking at the 55th percentile over the trailing 20Y window.
Cross-checking P/E against P/B, the two percentiles sit within 14.7 points of each other — a consistent signal from both angles. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Bmc Medical operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 301367 · SZSE: 301367 · 301367
Want the full picture on whether Bmc Medical (301367.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 26.00 | ||||||
| P/B (MRQ) | 1.88 | ||||||
| P/S (TTM) | 3.77 | ||||||
| Dividend Yield | 1.02% | ||||||
| Buyback + Div Yield | 1.06% |